Combined Behavioral and Pharmacologic Treatment of Polydrug Abuse
Sponsor
National Institute on Drug Abuse (NIDA) (NIH)
Overall Status
Completed
CT.gov ID
NCT00292123
Collaborator
(none)
200
86
Study Details
Study Description
Brief Summary
The primary goal of this study is to determine how contingency management can best be combined with standard or high doses of methadone to increase simultaneous abstinence from heroin and cocaine.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Phase 1 |
Detailed Description
A study of people pmaintained on Methadone using contingency management
Study Design
Study Type:
Interventional
Actual Enrollment
:
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Investigator)
Primary Purpose:
Treatment
Study Start Date
:
Jun 1, 1999
Actual Primary Completion Date
:
Jun 1, 2006
Actual Study Completion Date
:
Aug 1, 2006
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Opioid dependence; cocaine use
Exclusion Criteria:
- Medical or psychiatric conditions that would contraindicate participation in a methadone maintenance study; inability to give informed consent; inability to attend clinic seven days a week
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- National Institute on Drug Abuse (NIDA)
Investigators
- Principal Investigator: Kenzie Preston, PhD, NIFA Intramural Research Program
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00292123
Other Study ID Numbers:
- NIDAIRP 326
First Posted:
Feb 15, 2006
Last Update Posted:
Jan 12, 2017
Last Verified:
Dec 1, 2007